West Pharmaceutical Servi... (WST)
NYSE: WST
· Real-Time Price · USD
272.50
-0.66 (-0.24%)
At close: Oct 03, 2025, 3:59 PM
272.56
0.02%
After-hours: Oct 03, 2025, 05:45 PM EDT
West Pharmaceutical Services Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.96B | 2.9B | 2.89B | 2.88B | 2.88B | 2.93B | 2.95B | 2.93B | 2.86B | 2.88B | 2.89B | 2.91B | 2.93B | 2.88B | 2.83B | 2.68B | 2.52B | 2.33B |
Cost of Revenue | 1.91B | 1.89B | 1.89B | 1.87B | 1.85B | 1.84B | 1.82B | 1.81B | 1.77B | 1.76B | 1.75B | 1.74B | 1.74B | 1.7B | 1.66B | 1.59B | 1.53B | 1.46B |
Gross Profit | 1.05B | 1B | 1B | 1.01B | 1.03B | 1.09B | 1.13B | 1.12B | 1.09B | 1.12B | 1.14B | 1.16B | 1.19B | 1.18B | 1.17B | 1.09B | 991.5M | 869.6M |
Operating Income | 625M | 597.6M | 596.2M | 596.2M | 619.5M | 676M | 716.5M | 707.7M | 704.2M | 740.8M | 760.1M | 779.2M | 775.1M | 761.1M | 754.6M | 696M | 619.2M | 517.5M |
Interest Income | 17.1M | 17.5M | 19.6M | 24.2M | 28.4M | 29.4M | 28M | 21.5M | 14.2M | 9.6M | 5.1M | 2.5M | 1.4M | 1.2M | 1M | 900K | 700K | 700K |
Pretax Income | 611.2M | 582.4M | 600.2M | 604.8M | 627.1M | 683.8M | 715.7M | 676.1M | 626.4M | 669.2M | 700.6M | 750.6M | 797.2M | 784.1M | 769M | 705.9M | 621.7M | 509.3M |
Net Income | 487.7M | 467.2M | 492.7M | 499.6M | 524.9M | 568.7M | 593.4M | 559.4M | 518.7M | 552.1M | 585.9M | 630.6M | 685.6M | 684.4M | 661.8M | 612.5M | 519.2M | 423.1M |
Selling & General & Admin | 351.1M | 338.2M | 336.9M | 341.6M | 348.7M | 354.1M | 353.4M | 349.1M | 326.4M | 319.5M | 316.9M | 329.2M | 354.8M | 366M | 362.8M | 341.1M | 320.9M | 303.7M |
Research & Development | 69.4M | 67.8M | 69.1M | 69M | 69.9M | 68.9M | 68.4M | 65.9M | 63.1M | 61M | 58.5M | 56.3M | 55.8M | 55.2M | 52.8M | 52M | 51.4M | 48.4M |
Other Expenses | n/a | n/a | n/a | n/a | -7M | -7M | -7M | -7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 420.5M | 406M | 406M | 410.6M | 411.6M | 416M | 414.8M | 408M | 389.5M | 380.5M | 375.4M | 385.5M | 410.6M | 421.2M | 415.6M | 393.1M | 372.3M | 352.1M |
Interest Expense | 1.2M | 2.6M | 3.7M | 4.8M | 7M | 8.1M | 8.8M | 9.3M | 8.5M | 7.7M | 7.6M | 9.1M | 8.7M | 8.7M | 8.4M | 8M | 8.3M | 8.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.33B | 2.3B | 2.3B | 2.28B | 2.26B | 2.25B | 2.23B | 2.22B | 2.16B | 2.14B | 2.13B | 2.13B | 2.15B | 2.12B | 2.08B | 1.99B | 1.9B | 1.81B |
Income Tax Expense | 123.5M | 115.2M | 107.5M | 105.2M | 102.2M | 115.1M | 122.3M | 116.7M | 107.7M | 117.1M | 114.7M | 120M | 111.6M | 99.7M | 107.2M | 93.4M | 102.5M | 86.2M |
Shares Outstanding (Basic) | 72.3M | 72.5M | 73M | 72.8M | 73M | 73.5M | 74.1M | 74.3M | 74.3M | 74.5M | 74.4M | 74.4M | 74.4M | 74.4M | 74.5M | 74.1M | 74M | 73.9M |
Shares Outstanding (Diluted) | 72.8M | 73M | 73.7M | 73.4M | 73.7M | 74.3M | 75M | 75.3M | 75.4M | 75.7M | 75.6M | 75.7M | 75.8M | 76M | 76.4M | 76M | 75.7M | 75.8M |
EPS (Basic) | 6.72 | 6.42 | 6.75 | 6.81 | 7.11 | 7.68 | 7.99 | 7.52 | 6.97 | 7.41 | 7.87 | 8.47 | 9.22 | 9.22 | 8.92 | 8.27 | 7.01 | 5.72 |
EPS (Diluted) | 6.68 | 6.37 | 6.69 | 6.74 | 7.03 | 7.58 | 7.88 | 7.41 | 6.86 | 7.29 | 7.73 | 8.30 | 9.02 | 9.00 | 8.70 | 8.06 | 6.84 | 5.58 |
EBITDA | 760.4M | 731M | 744.6M | 744.2M | 764.4M | 816.9M | 844.1M | 800.3M | 742.8M | 780.3M | 807.7M | 865.7M | 910.4M | 892.9M | 879.6M | 806.5M | 721.8M | 610.3M |
EBIT | 598.1M | 571.2M | 589.2M | 593.6M | 618.3M | 675.6M | 706.8M | 667.8M | 616.2M | 657.7M | 687.1M | 741.8M | 786.3M | 770.1M | 757.3M | 690.1M | 602.8M | 493.9M |
Depreciation & Amortization | 162.3M | 159.8M | 155.4M | 150.6M | 146.1M | 141.3M | 137.3M | 132.5M | 126.6M | 122.6M | 120.6M | 123.9M | 124.1M | 122.8M | 122.3M | 116.4M | 119M | 116.4M |